The potential of PDHA1 as a cuproptosis-related prognostic and immune biomarker in lung squamous cell carcinoma.

Zheng S, Huang Z, Wang G, Chen J, Guan S, Chen Z, Wang M, Wang M, Huang Z

Open source

DOI
10.1080/1750743x.2026.2751904
Published
2026 Oct 27
Container
Immunotherapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/1750743x.2026.2751904,
  title = {The potential of PDHA1 as a cuproptosis-related prognostic and immune biomarker in lung squamous cell carcinoma.},
  author = {Zheng S and Huang Z and Wang G and Chen J and Guan S and Chen Z and Wang M and Wang M and Huang Z},
  year = {2026},
  journal = {Immunotherapy},
  doi = {10.1080/1750743x.2026.2751904},
  url = {https://doi.org/10.1080/1750743x.2026.2751904}
}

RIS

TY  - JOUR
TI  - The potential of PDHA1 as a cuproptosis-related prognostic and immune biomarker in lung squamous cell carcinoma.
AU  - Zheng S
AU  - Huang Z
AU  - Wang G
AU  - Chen J
AU  - Guan S
AU  - Chen Z
AU  - Wang M
AU  - Wang M
AU  - Huang Z
PY  - 2026
JO  - Immunotherapy
DO  - 10.1080/1750743x.2026.2751904
UR  - https://doi.org/10.1080/1750743x.2026.2751904
ER  - 

APA

S, Z., Z, H., G, W., J, C., S, G., Z, C., M, W., M, W., & Z, H. (2026). The potential of PDHA1 as a cuproptosis-related prognostic and immune biomarker in lung squamous cell carcinoma.. Immunotherapy. https://doi.org/10.1080/1750743x.2026.2751904

Source records